© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
October 02, 2020
The risk of VTE is increased in both hospitalized and non-hospitalized COVID-19 patients.
October 01, 2020
This edition from the 10 Year Plan features perspective from leadership at ACC and ESC, as well as survey results from cardiologists.
September 30, 2020
Ongoing trials are essential to confirming semalutide’s role in decreasing risk of chronic kidney disease in patients with type 2 diabetes
September 29, 2020
These recommendations were developed with the primary goal of improving outcomes in cardiovascular mortality.
September 28, 2020
Between 1999 and 2016, cardiovascular disease prevalence declined at a much faster for the highest-income earners than the rest of the population.
September 25, 2020
For obese patients, both weight gain and loss was linked to an increase in the rate of incident venous thromboembolism.
September 23, 2020
This decrease in hospital admissions had no association with regional prevalence of COVID-19.
September 21, 2020
Treatments for VTE in children fall short as they require frequent monitoring and include unpredictable food and drug interactions.
September 19, 2020
Individuals in vulnerable populations had a higher proportion and odds of not being vaccinated within the past year.
September 18, 2020
Ustekinumab should be prescribed cautiously to those at high cardiovascular risk.